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Abstract 
This study explored the role of clusterin in mechanism~ of cell adhesion and apopto~is n PI9 embryonic arcinoma cells. We found 
that serum deprivation i duced transient but dramatic elexation in cell adhe~,irul strength to the culture substrate and eventuany led to 
apoptotic ell death. The time course of cell-adhesion i crease overlapped temporall~ with the elevation of clusterin mRNA (peak 8 h 
after semm deprivation). The coincidental e evation of clusterin expression and cell adhesion strength preceded the schedule of apoptotic 
cell death. Clusterin antiserum partially antagonized cell adhesion, but did not modif) the course of apoptosis. These data suggest that 
clusterin expression may partially control cell adhesion with no influence on apopto~i> n PI9 cells, under defined conditions. 
Keywords: Apolipoprotein J: Sulfated glycoprotein-2: Testosterone repressed me~,age-2: Clu~terin expression: Apoptosis: Serum deprivation-induced cell 
death 
1. Introduction 
Clusterin is an amphiphilic glycoprotein found in many 
tissues and fluids, for which several possible functions 
have been proposed. Originally named for its activity in 
aggregating (clustering) spermatozoa [I]. clusterin has nu- 
merous other acronyms, derived from various attributes 
and associations, that include complement lysis inhibition 
(CLL SP-40,40) [2,3] and apolipoprotein transport (apoJ) 
[4]. It is also known as sulfated glycoprotein 2 (SGP-2) [5]. 
When identified as a testosterone r pressed message-2 
(TRPM-2), its induction was associated with apoptosis in 
certain epithelial and mesenchymal cells, e.g.. in the 
prostate after castration [6], kidney ducts after ureteral 
obstruction [7] and with iieurodegeneration [8]. Although 
clusterin is often increased in regressing or injured tissues• 
it cannot be regarded as a marker of cell death because of 
its constitutive xpression by many types of healthy cells 
in several tissues and organs, including the brain [9.10]. 
Moreover, in several in vivo models of cell death, clusterin 
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mRNA was shown to be selectively upregulated in surviv- 
ing cells [11-13] while clusterin depletion was shown to 
enhance injury [14]. There is also evidence that clusterin 
may be involved in mechanisms of cell-adbesion [15,16] 
which may be pertinent to its role in tissue reorganization 
after injury [17,18]. 
The precise biological function(s) of clusterin in mecha- 
nisms of cell death/survival is unknown. 
In this study we further examined the role of clusterin 
in PI9 embryonic carcinoma cells during responses to 
serum deprivation, in these conditions we have previously 
shown that P I9 cells undergo apoptotic ell death, showing 
DNA fragmentation• partially inhibited by cycloheximide, 
and the typical changes in nuclear morphology [19]. Here 
we describe a transient increase in cell adhesion in the 
same cells and a coincidental regulation of clusterin ex- 
pression, which preceded the onset of apoptotic nuclear 
fragmentation. Clusterin antiserum partially antagonized 
the changes in cell adhesion, but failed to prevent the 
morphological changes characteristic of apoptosis. This 
study suggests alternative role(s) of clusterin during re- 
sponse to stimuli leading to apoptosis• under defined con- 
ditions. 
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2. Materials and methods 2.4. RNA analysis (Northern blot) 
2.1. Cell culture 
PI9SI801AI (PI9) cell culture and media composition 
were as previously described [19]. Briefly, cells were 
dissociated with pancreatin (0.4 X U.S.P.; Gibco. Paisley, 
UK), washed once with complete medium (Dulbecco's 
Modified Eagles Medium plus 10% fetal calf serum (FCS)), 
twice with serum-free medium and plated in 25 em 2 tissue 
culture flasks (Falcon Becton Dickinson, Lincoln Park, 
New Jersey) at a final density of 104 cells/cm 2 in 5 ml of 
serum-free or complete medium. Cells were examined for 
cell adhesion strength to culture substrate (plastic), apopto- 
sis (nuclear morphology) and clusterin expression (mRNA 
and protein). 
When indicated, flasks were coated overnight with hu- 
man fibrinogen (grade L, Ortho Diagnostic Systems. Mi- 
lan, Italy) 250 #g/ml  in PBS with Ca 2÷ and Mg 2÷. then 
I h with 1% bovine serum albumin, followed by three 
washes with PBS. 
2.2. Cell adhesion assay 
Quantitation of cell adhesion was made as previously 
described, with minor modifications [20]. Briefly, after 
removal of culture medium, cells were incubated with 0.5 
ml pancreatin for a defined time (usually 3 min) at 37°C in 
a water bath, then 1 ml of complete medium was gently 
distributed over the surface of the culture to inactivate 
pancreatin and collect detached cells (with no shaking). 
The number of detached cells was determined by counting 
cells that excluded Trypan blue in an aliquot of the 1.5 ml 
suspension, in a standard hemocytometer. This procedure 
is sufficient o detach about 50% of the cells in normal 
control P19 cultures in 1 min, 70% in 3 min and 100% in 5 
min. A lower number of detached cells was indicative of a 
higher number of cells that were resistant to proteolitic 
detachment and, by consequence, of a higher strength of 
adhesion to substrate. 
2.3. Nuclear morphology 
Pl9 cells were collected by gently pipetting, resus- 
pended in serum-free medium and seeded on microscope 
slides by cytospin centrifugation (Heraeus, Handu, Ger- 
many) at 600 rpm for 5 rain. They were then fixed in 
Carnoy solution (methanol:acetic acid, 3:1) for 1 h, stained 
with Hoechst 33258 (0.1 ~g/ml  in phosphate-buffered 
saline) for I h at 37°(2. washed with tap water for 1 h, 
air-dried and mounted. Slides were examined with a fluo- 
rescence microscope (Zeiss, Oberkochen, Germany) at an 
excitation wavelength of 365 rim, counting at least 500 
cells in triplicate preparations [19]. 
Total RNA was extracted from individual samples with 
a standard guanidinium thiocyanate-CsCl method [21]. To- 
tal RNA (10 /xg) was electrophoresed on denaturing (0.2 
M formaldehyde) agarose gels in MOPS buffer (MOPS 40 
mM, Na-acetate 10 mM, EDTA 1 mM, pH 8) for 5 h at 70 
Volts, and blotted to nylon membrane (Gene Screen TM
Plus, DuPONT, Dreieich, Germany) in 10 x SSC (NaCI 
1.5 M, sodium citrate trisodium salt dihydrate 15 mM, pH 
7). Antisense [32p]cRNA for clusterin was transcribed 
from linearized eDNA transcription vector; the rat clus- 
terin cDNA clone was a gift from M. Griswold (University 
of Washington, Pullman). RNA blots were hybridized with 
l06 CPM/ml. Blots were washed to a final stringency of 
0.2 X SSC, 0.2% SDS at 72°C, then exposed to Kodak 
XAR-5 X-ray film (Eastman Kodak, Rochester, NY) with 
intensifying screen at -70°C. Northern blot hybridization 
of P19 total RNA with labelled clusterin cRNA detected 
the expected single mRNA band of 2.0 kb [10,22,23]. 
Integrated optical densities were collected by computerized 
video densitometry (Image Measure, Microscience, Fed- 
eral Way, WA). Data were analyzed by ANOVA followed 
by LSD post hoc analysis. 
2.5. Protein analysis (Western blot) 
P19 cells, cultured in serum-free medium were col- 
lected, centrifuged at 150 ×g and resuspended in lysis 
hufier (20 mM Tris-HCI, pH 7.0, l mM EDTA, 0.5 mM 
benzamide, 0.01% soybean trypsin inhibitor). Cells were 
lysed by 5 freeze/thaw cycles, centrifuged at 13000 × g 
for 15 min at room temperature, then pellets and super- 
natants were separated. The pellet is a fraction rich in 
plasma membranes, nuclei, mitochondria, Golgi vesicles 
and lysosomes, and the supernatant includes cytosol and 
microsomes [24]. Protein content was determined by 
Lowry's method [25]. Proteins (20 p,g/sample) and condi- 
tioned media (concentrated 40-fold on 30 kDa cut-off 
Centricon concentrators (Amicon, Beverly, MD) were re- 
suspended in 62.5 mM Tris-HCl, pH 6.8, containing 100 
mM DTT, 8 M urea, 5% (w/v) glycerol and 0.01% 
bromophenol b ue tracking dye and resolved in 10% SDS- 
polyacrylamide gels by the discontinuous method of 
Laemmli [26], as modified by Douglas and Butow [27]. 
Gels were blotted onto nitrocellulose membrane (Schleicher 
and Schuell, Dassel, Germany) for 3 h at 70 V. Mem- 
branes were stained with Ponceau-S, blocked in Tris- 
buffered saline (TBS) containing 0.075% Tween and 0.1% 
bovine serum albumin for l h at room temperature, and 
immunoreacted with a rabbit anti-rat clusterin antiserum 
(1:500 dilution from stock, from M. Griswold) [10,22,28]. 
Immunoreactivity was visualized by chemiluminescence 
(ECL, Amersham) and molecular weights (kDa) were cal- 
culated from standards (Bio-Rad, Richmond, CA). The 
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same clusterin antiserum (IgG fraction) was used for im- 
munoblotting and adhesion assays. 
3.  Resu l ts  
Changes of cell adhesion, apoptosis and clusterin ex- 
pression were examined in PI9 cells at each time indicated 
after plating in serum free or complete medium. Fig. IA.B 
shows the morphology of PI9 cells 24 h after plating in 
conditions of complete (A), or serum free (B) medium. At 
this time all cells, also in B, were attached to culture 
substrate (plastic) and were viable, as assessed by Trypan 
~ ~i , ,~  : ,~ ,  ,~ A 
Q 
Fig. I. Morphology of PI9 cells. Phase-contrast photomicrographs of PI9 
cells either in complete (A) or in serum-free (B) medium 24 h after 
plating. At this stage cells in serum-free medium are still attached to
substrate, but are organized inclusters. (C) Nuclear moq~hology of cells. 
stained with Hoechst 33258, 36 h after plating in serum-C-ee medium. 
Nuclei presenting chromatin condensation a d fragmentation character- 
istic of apoptosis are visible, together with normal nuclei, with dispersed 
chromatin and larger in size. Original magnification 100x in A and B. 
400× in C. Bar 50 ,tim in A and B, 8 ~,m ial C. 
2OO 
otl II III 
' ' 2' hours 
i , T u 
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Fig. 2. Time cour~.e of change of PI9 cell adhesion to substrate in
response to serum deprivation. Cells were plated at the density of 
2.5 x lOS/flask in either complete (fetal calf serum, FCS) or serum-free 
medium. Cell adhe~.ion strength was quantified by counting the number of
cells that could be .tetached by a limited proteolytic treatment (3-rain 
pancreatin i cubation, see Section 2.2) at 2. 8 and 24 h after plating in 
complete (FCS) or in serum-free medium. A lower number of detached 
cells ',','as indicative of a higher number of cells that were resistant to
proteolitic detachment and. by consequence, of a hie.her strength of 
adhesion to substrate. Means + S.D.. n = 4 per group. 
blue exch,::ion (not shown). In Fig. IC we show represen- 
tative nuclei stained with Hoeehst 33258, with the typical 
apoptotic morphology. The proportion of apoptotic nuclei 
in serum-deprived cells was less than 2% by 8 h after 
plating, and reached 15% and 25,% by 24 and 36 h, 
respectively (not shown) [19]. 
PI9 cells in serum-free medium (Fig. IB) showed a 
non-homogeneous distribution as compared to cells in 
complete medium (Fig. IA), and were organized in clus- 
ters. We therefore hypothesized that, despite the same 
attachment, they could show differences in adhesion. We 
found that at 2 and 8 h after plating in serum-free condi- 
tions, PI9 cells adhered more strongly to the culture 
substrate when compared with cultures in complete- 
medium (Fig. 2). Cell adhesion was quantified by counting 
the number of cells that could be detached by a limited 
proteolytic treatment (see Section 2.2 and Ref. [20"1). P!9 
cells reached maximum cell adhesion by 8 h after plating 
in serum-free medium, returning toward control levels by 
24 I1 (Fig. 2). The time course of cell adhesion increase 
was therefore considerably faster as compared with the 
appearance of apoptotic figures in the same cells (see 
above and Ref. [19]). 
The same difference in adhesion, although to a lower 
extent, was observed when cells were cultured on fibrino- 
gen-coated flasks: the number of cells detached by 3 min 
incubation with panereatin, by 8 h after plating, was 
282400+_46300 and 165300+27300 for control and 
serum free cells, respectively (mean 4- S.D., n = 4. P < 
0.01, Student's t-test). 
The time course of changes of cell adhesion coincided 
with the peak elevation of clusterin mRNA (Fig. 3A,B). 
Northern blot hybridization of total RNA from PI9 cells 
with rat cRNA probes detected a single 2.0 kb mRNA 
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Fig. 3. Time course of clusterin mRNA changcs in PI9 cells following serum deprivation. In A, the upper panel shows clusterin mRNA Northern blot 
hybridization signal of total RNA I?om PI9 cells 2. 8 and 24 h after plating in complete (FCS) or in serum-free medium. In the lower panel, ethidium 
bromide staining controlled tor RNA loading. In B. time course of clusterin InRNA change as assessed by Northern blot assay. Mean ± S.E.M. of the 
results t¥om 4-5 independent determinations. " P < 0.05. 
species, as previously found in rat and human brain [10] 
(Fig. 3A). As assessed by Northern blot hybridization 
assay, the schedule of clusterin mRNA change, overla?ped 
temporally with tk, schedule of cell adhesion showing a 
coincidental peak elevation by 8 h after plating in serum- 
free conditions (Fig. 3B). 
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Fig. 4. Inhibition of cell-adhesion strength, but not of apopto~i~ by
clusterin antiserum. In A, cells were plated either in complete medium 
(FCS) or serum-free medium supplemented with saline (-). two dilutions 
of a rabbit anti-rat clusterin polyclonal ntiserum tab 1/400 and 1/200), 
or preimmune rabbit serum (serum 1/200). Adhesion strength was then 
measured as the number of cells that could be detached by proteolytic 
treatment. S h after plating. In B. the number of apoptotic nuclei was 
determined 36 h after plating. Mean+S.D. n= 4-5 per group. ' " P < 
0.01 and " P <" 0.(15 ~r, the group with no antiserum ( - ). 
Using rabbit anti-rat (IgG) clusterin antiserum, im- 
munoblots of P I9 cells under reducing conditions revealed 
two bands of about 36 and 39 kDa (not shown), in 
agreement with the electrophoretic pattern of the processed 
dimeric forms of rat brain (and serum) clusterin [10,22]. 
Clusterin immunoreactivity was detectable in the cytosolic 
fraction by 2 and 8 h and transiently, in the membrane 
fraction by 8 h after plating in serum-free conditions. No 
clusterin immunoreactivity was found in both fractions by 
24 h after plating and in the concentrated (40-fold) condi- 
tioned media at any time examined (2, 8 and 24 h) (not 
shown). 
To assess the role of clusterin in P I9 cells during 
conditions of serum deprivation, we examined the effect of  
the same clusterin antiserum on cell adhesion strength and 
apoptosis. While clusterin antiserum (1:400, 1:200 dilu- 
tions) partially reduced cell adhesion strength by 8 h (Fig. 
4A), it failed to block apoptosis by 36 h after plating (Fig. 
4B). Control pre-immune rabbit serum was negative on 
both conditions (Fig. 4A,B). The increase in the number of 
detachable cells obtained by clusterin antiserum in three 
independent experiments was 192 + 14% (mean + S.D.) of  
untreated, serum-deprived cells. 
4. Discussion 
This study explored the role of clusterin in mechanisms 
of cell adhesion and apoptosis and extends previous stud- 
ies on mechanisms of apoptotic ell death in P I9 carci- 
noma cells during responses to serum deprivation [19]. 
While there is evidence that clusterin expression is ele- 
vated in several models of neurodegeneration [22,28], tis- 
sue regression [I I] and apoptosis [6], the precise biological 
function(s) of this protein is far from being understood. 
In our study we show that clusterin antiserum partially 
antagonized the increase in cell adhesion that occurred in 
serum deprived P I9 cells prior to the occurrence of nuclear 
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fragmentation. However, it failed to affect apoptosis which 
may also be due to the tact that the clusterin antiserum did 
not have access to intracellular mechanisms leading to 
• ,poptosis. This study suggests therefore that clusterin could 
control cell-adhe.dve mechanisms, irrespective to condi- 
tions leading to apoptosis in the same cells. This perspec- 
tive is consi.,,tet t with the discrepancy on the role of 
clvsterin in cell death (apoptosis) and/or  tissue regres- 
sion/remodelling, reported in several experimental mod- 
els, in vivo or in vitro (see Section I). Moreover. recent 
data show that clusterin depletion rather than its expression 
is associated with cell death, and suggest hat clusterin 
plays a role in the protection against death [11-14,29]. 
Since clusterin is a secretory protein (in testis, adrenal 
glands, as well as astrocytes, etc., summarized in Ref. 
[10]), the absence of clusterin in the conditioned media is 
puzzling. However. it does not imply that ctusterin is not 
secreted by PI9 cells. We cannot exclude that the protein 
is present in the cell matrix. Additionally. it has recently 
been reported tha! glycoprotein 3311, a protein relateC to 
the low density lipoprotein receptor, can bh~d clusterin and 
mediate its internalization i F9 teratocarcinoma cells [301 
Clusterin may therefore be secreted and then rapidly bound 
in serum-deprived P19 cells too. Since our membrane-en- 
riched fraction also contains organelles uch as lysosomes. 
our data are compatible both with the presence of clusterin 
at the cell surface and with its internalization. 
Clusterin (GP80) has also been attributed a cell-ad- 
hesive role during tissue remodelling as shown in the slime 
mold Dic tyoste l ium d isco idet tm during development 
[31,32]. Moreover. during response to experimental brain 
lesions, the elevation of clusterin expression is also local- 
ized in regions where synaptic remodelling occurs [33,34]. 
Thus, clusterin could also play a role in synaptic reorgani- 
zation through its cell adhesion properties. 
The time course of clusterin mRNA increase paralleled 
the increase of adhesion strength, both peaking 8 h after 
serum deprivation. At this time after plating in serum free 
conditions, the increase in adhesion strength was signifi- 
cantly lowered by the addition of clusterin antiserum at 
two concentrations, which were equally effective, suggest- 
ing a ceiling effect. Although the inhibition of cell adhe- 
sion by clusterin antiserum was only partial, it was consis- 
tently found in three independent experiments, uggesting 
a significant role of clusterin in cell adhesion. We note that 
other factors besides clusterin might control cell adhesion 
in PI9 cells. 
In conclusion our s',ndy indicates that clustcrin does not 
play a pivotal role in the causative pathways that lead to 
cell death, but it may contribute to the adhesive interac- 
tions with the substrate. Moreover our study in PI9 cells 
raises new questions about alternative functions of clus- 
terin in regressing tissues. PI9 cells under condition of 
serum deprivation provide an invaluable in vitro model to 
further assess the role of clusterin in mechanisms of cell 
adhesion and apoptotic ell death in the same cells. 
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